
Cryptating agent 222
CAS No. 23978-09-8
Cryptating agent 222( Cryptate 222 | NSC 264495 | NSC-264495 | NSC264495 )
Catalog No. M27321 CAS No. 23978-09-8
Cryptating agent 222 is a cryptand used with potassium mirror to reduce a hindered distannene to a crystalline radical anion and forms ligands with metal cations.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 45 | In Stock |
![]() ![]() |
10MG | 68 | In Stock |
![]() ![]() |
25MG | 115 | In Stock |
![]() ![]() |
50MG | 173 | In Stock |
![]() ![]() |
100MG | 258 | In Stock |
![]() ![]() |
200MG | 388 | In Stock |
![]() ![]() |
500MG | 642 | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameCryptating agent 222
-
NoteResearch use only, not for human use.
-
Brief DescriptionCryptating agent 222 is a cryptand used with potassium mirror to reduce a hindered distannene to a crystalline radical anion and forms ligands with metal cations.
-
DescriptionCryptating agent 222 is a cryptand used with potassium mirror to reduce a hindered distannene to a crystalline radical anion and forms ligands with metal cations.
-
In Vitro——
-
In Vivo——
-
SynonymsCryptate 222 | NSC 264495 | NSC-264495 | NSC264495
-
PathwayOthers
-
TargetOther Targets
-
RecptorBACE1|Beta-secretase|Apoptosis|P. falciparum
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number23978-09-8
-
Formula Weight376.494
-
Molecular FormulaC18H36N2O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC1COCCN2CCOCCOCCN(CCO1)CCOCCOCC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
3-Hydroxybenzoic aci...
Produced in the gut microflora as one of the three main metabolites formed from the catechin diet. Its use in the production of glycol benzoates for the application of plasticizer in adhesive formulations is increasing.
-
MeAIB
MeAIB is an N-acetyltransferase inhibitor that inhibits SNAT2-related signaling pathways. MeAIB is a specific substrate for amino acid transport system a (ATA1).
-
Syk Inhibitor II hyd...
The impact of spleen tyrosine kinase (Syk) signaling might be prominent in lupus because (i) Syk is a shared downstream signaling molecule among circulating immune complex, LPS, and (1→3)-β-D-glucan (BG), and (ii) all of these factors are detectable in the serum of Fc gamma receptor IIb-deficient (FcgRIIb-/-) mice with sepsis. Syk inhibition downregulated several inflammatory pathways in FcgRIIb-/- macrophages activated with BG + LPS suggesting the potential anti-inflammatory impact of Syk inhibitors in lupus.